Yuuka Shibata
Hiroshima University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yuuka Shibata.
Biochemistry and biophysics reports | 2016
Yuuka Shibata; Tomoharu Yokooji; Ryo Itamura; Yumeka Sagara; Takanori Taogoshi; Katsunari Ogawa; Maiko Tanaka; Michihiro Hide; Kenji Kihira; Hiroaki Matsuo
Inadvertent leakage of medications with vesicant properties can cause severe necrosis in tissue, which can have devastating long-term consequences. The aim of this study was to evaluate the extent of extravasation injury induced by thiopental and propofol, and the effects of cooling or warming of local tissue on extravasation injury at macroscopic and histopathologic levels. Rats were administered intradermally thiopental (2.5 mg/100 µL) or propofol (1.0 mg/100 µL). Rats were assigned randomly to three groups: control (no treatment), cooling and warming. Local cooling (18–20 °C) or warming (40–42 °C) was applied for 3 h immediately after agent injection. Lesion sizes (erythema, induration, ulceration, necrosis) were monitored after agent injection. Histopathology was evaluated in skin biopsies taken 24 h after agent injection. Thiopental injection induced severe skin injury with necrosis. Peak lesions developed within 24 h and healed gradually 18–27 days after extravasation. Propofol induced inflammation but no ulceration, and lesions healed within 1–2 days. Local cooling reduced thiopental- and propofol-induced extravasation injuries but warming strongly exacerbated the skin lesions (e.g., degeneration, necrosis) induced by extravasation of thiopental and propofol. Thiopental can be classified as a “vesicant” that causes tissue necrosis and propofol can be classified as an “irritant”. Local cooling protects (at least in part) against skin disorders induced by thiopental and propofol, whereas warming is harmful.
Biological & Pharmaceutical Bulletin | 2016
Yuuka Shibata; Yasuhiro Kimura; Takanori Taogoshi; Hiroaki Matsuo; Kenji Kihira
Intraocular irrigating solution containing 1 µg/mL adrenaline is widely used during cataract surgery to maintain pupil dilation. Prepared intraocular irrigating solutions are recommended for use within 6 h. After the irrigating solution is admistered for dilution, the adrenaline may become oxidized, and this may result in a decrease in its biological activity. However, the stability of adrenaline in intraocular irrigating solution is not fully understood. The aim of this study was to evaluate the stability of adrenaline in clinically used irrigating solutions of varying pH. Six hours after mixing, the adrenaline percentages remaining were 90.6%±3.7 (pH 7.2), 91.1%±2.2 (pH 7.5), and 65.2%±2.8 (pH 8.0) of the initial concentration. One hour after mixing, the percentages remaining were 97.6%±2.0 (pH 7.2), 97.4%±2.7 (pH 7.5), and 95.6%±3.3 (pH 8.0). The degradation was especially remarkable and time dependent in the solution at pH 8.0. These results indicate that the concentration of adrenaline is decreased after preparation. Moreover, we investigated the influence of sodium bisulfite on adrenaline stability in irrigating solution. The percentage adrenaline remaining at 6 h after mixing in irrigating solution (pH 8.0) containing sodium bisulfite at 0.5 µg/mL (concentration in irrigating solution) or at 500 µg/mL (concentration in the undiluted adrenaline preparation) were 57.5 and 97.3%, respectively. Therefore, the low concentration of sodium bisulfite in the irrigating solution may be a cause of the adrenaline loss. In conclusion, intraocular irrigation solution with adrenaline should be prepared just prior to its use in surgery.
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2005
Yuuka Shibata; Hiroaki Ikeda; Yoshihiro Kondou; Kenji Kihira
Japanese Journal of Pharmaceutical Health Care and Sciences | 2006
Yasuhiro Kimura; Yuuka Shibata; Yuka Shozuhara; Honami Doi; Kenji Kihira
Japanese Journal of Ophthalmology | 2014
Yuuka Shibata; Yuta Tanaka; Takashi Tomita; Takanori Taogoshi; Yasuhiro Kimura; Tai-ichiro Chikama; Kenji Kihira
Japanese Journal of Pharmaceutical Health Care and Sciences | 2008
Yasuhiro Kimura; Osamu Ohhama; Honami Doi; Yuuka Shibata; Kenji Kihira
Japanese Journal of Pharmaceutical Health Care and Sciences | 2007
Yuuka Shibata; Hiroaki Ikeda; Hisaya Fujiwara; Yuko Kaneyasu; Mayu Yunokawa; Yukari Itakura; Kazumi Isobe; Yasuyuki Saeki; Satoru Izumitani; Hiroko Unei; Masayuki Nishihara; Yosiki Kudo; Kenji Kihira
The Journal of Japan Society for Clinical Anesthesia | 2014
Yuuka Shibata; Masashi Kawamoto; Kenji Kihira
Japanese Journal of Pharmaceutical Health Care and Sciences | 2008
Yuuka Shibata; Hiroaki Ikeda; Toshimichi Yasuda; Hiroko Unei; Yasuyuki Saeki; Keiko Fujita; Masashi Kawamoto; Kenji Kihira
Biological & Pharmaceutical Bulletin | 2018
Yuuka Shibata; Yumeka Sagara; Tomoharu Yokooji; Takanori Taogoshi; Maiko Tanaka; Michihiro Hide; Hiroaki Matsuo